Cargando…
TGF-β in T Cell Biology: Implications for Cancer Immunotherapy
Transforming Growth Factor beta (TGF-β) is a pleiotropic cytokine produced in large amounts within cancer microenvironments that will ultimately promote neoplastic progression, notably by suppressing the host’s T-cell immunosurveillance. This effect is mostly due to the well-known inhibitory effect...
Autores principales: | Dahmani, Amina, Delisle, Jean-Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025055/ https://www.ncbi.nlm.nih.gov/pubmed/29891791 http://dx.doi.org/10.3390/cancers10060194 |
Ejemplares similares
-
NK Cell Metabolism and TGFβ – Implications for Immunotherapy
por: Slattery, Karen, et al.
Publicado: (2019) -
T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies
por: Janelle, Valérie, et al.
Publicado: (2021) -
Targeting immunosuppression by TGF-β1 for cancer immunotherapy
por: de Streel, Grégoire, et al.
Publicado: (2021) -
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy
por: Tschernia, Nicholas P., et al.
Publicado: (2022) -
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: Benjamin, David J., et al.
Publicado: (2021)